Bristol-Myers Squibb Co. v. Teva Pharm. United States, Inc.
135 S. Ct. 2050, 191 L. Ed. 2d 956, 83 U.S.L.W. 3836, 2015 U.S. LEXIS 3051
This text of 135 S. Ct. 2050 (Bristol-Myers Squibb Co. v. Teva Pharm. United States, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Bristol-Myers Squibb Co. v. Teva Pharm. United States, Inc., 135 S. Ct. 2050, 191 L. Ed. 2d 956, 83 U.S.L.W. 3836, 2015 U.S. LEXIS 3051 (U.S. 2015).
Opinion
Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
135 S. Ct. 2050, 191 L. Ed. 2d 956, 83 U.S.L.W. 3836, 2015 U.S. LEXIS 3051, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bristol-myers-squibb-co-v-teva-pharm-united-states-inc-scotus-2015.